Add Labs

"The mini-labs provide a flexible test environment that delivers real measurement data," Gamella said in a statement. "They're a bit like a playground for algorithms, where researchers can test their AI beyond simulated data in a controlled and safe environment."

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

ReviewAI, a product developed by St. John's-based tech company CoLab Software, can comb through data and knowledge of past engineering projects to provide insight, improvements and make sure mistakes found in the past aren't repeated.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

In a statement, NETSOL said the initiative is designed to empower automotive and equipment original equipment manufacturers (OEMs), dealerships, and financiers with advanced AI so

Now, Google is also launching a similar initiative, which aims to turn AI into a co-scientist that can accelerate scientific discoveries. The tech giant explains, "The AI co-scientist is a multi-agent AI system that is intended to function as a collaborative tool for scientists."

The National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science user facility at DOE's Brookhaven National Laboratory—is among the world's most advanced synchrotron light sources,

Quinnox, an AI-first, digital-native technology leader, is driving AI-powered transformation through QAI Studio, a dedicated AI innovation lab designed to help enterprises fast-track AI adoption and achieve measurable business outcomes.